Our study is the first one to provide the solid evidence that AMPK is an upstream kinase that phosphorylates KLF10 at Thr189, resulting in the protein interaction and the repressive activity on SREBP-1C leading to downregulation of NAFLD. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.